RxDoctor Payments Data

Mounir Soliman

Psychiatry · la Jolla, CANPI 1790701050

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,050 of the $4,142 with a category attached, or 97.8%. AbbVie accounts for 97.8% of it on its own, with 2 other manufacturers making up the rest. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,142in general payments, 2019–2025

Across 3 payments — averaging $1380.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Neurocrine Biosciences, Inc.$53
  • Livanova USA, Inc.$39
$1,431,407in research payments, 2019–2025

Across 282 payments — averaging $5075.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$797K
  • AbbVie$224K
  • Sunovion Pharmaceuticals Inc.$104K
  • Livanova USA, Inc.$97K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$45K
  • Neurocrine Biosciences, Inc.$45K
  • plus $119K from 6 others

What the payments were for

  • Consulting fees$4,05098%
  • Food & beverage$922%

General payments by program year

21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1$4,050
Neurocrine Biosciences, Inc.1$53
Livanova USA, Inc.1$39

How this compares

$4,142 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in la Jolla

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →